Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study.
Srihari GopalJagadish GogateKatalin PungorEdward KimArun SinghMaju MathewsPublished in: Neuropsychiatric disease and treatment (2020)
ClinicalTrials.gov Identifier: NCT01515423.